Knoll Capital Management, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Knoll Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	BUY	$4.29 - $5.64 $257,400 - $338,400	60,000 Added 1.2%	5,045,870 $27.6 Million
Q1 2019 May 15, 2019	BUY	$5.76 - $8.95 $5.32 Million - $8.26 Million	923,079 Added 22.72%	4,985,870 $34.7 Million
Q3 2018 Nov 14, 2018	BUY	$4.65 - $7.95 $692,464 - $1.18 Million	148,917 Added 3.8%	4,062,791 $30.5 Million
Q2 2018 Aug 14, 2018	BUY	$5.05 - $6.8 $287,289 - $386,845	56,889 Added 1.47%	3,913,874 $19.8 Million
Q4 2017 Feb 14, 2018	BUY	$6.6 - $7.78 $779,196 - $918,506	118,060 Added 3.16%	3,856,985 $27.4 Million
Q3 2017 Nov 14, 2017	BUY	$5.75 - $7.75 $21.5 Million - $29 Million	3,738,925	3,738,925 $26.7 Million

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.23B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Knoll Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Knoll Capital Management, LLC with notifications on news.